Previous (2011) Technical Conference

Keynote Session

June 29 [Wed] 13:30-15:50

Global Trends of Pharmaceutical & Biotech

10th Anniversary Session

June 30 [Thur] 15:50-17:20

Keys to Re-energize Japanese Bio Industry

INTERPHEX JAPAN
Keynote Session

June 29 [Wed] 10:30-12:30

Expanding Strategies of Growing Pharmas

COSMETICS JAPAN
Keynote Session

June 30 [Thur] 10:30-12:00

Technical Innovations in Cosmetics Industry

Time Table

June 29 (Wed)	June 30 (Thur)		July 1 (Fri)
10:30-12:00	10:30-12:00	13:00-14:30	10:30-12:00	14:00-15:30
- 1 - Epigenome	- 2 - Medical Innovation Strategies & Pharma Administration and Regulations	- 4 - Regenerative Medicine and Cancer Treatment	- 6 - Practical Realization of ES/iPS Cell	- 8 - New Stage of Drug Development
	- 3 - Frontline of Vaccine Development	- 5 - Intellectual Property Strategy	- 7 - Asian Innovations in Drug Discovery	- 9 - RNA Drug Discovery

BIO-Kブロック

BIO-K

Keynote Session

June 29 (Wed) 13:30-15:50Bilingual (English/Japanese)

What is Happening in Global pharma world with growing Asia and Synthetic Genome?

Session Chair:Ken-ichi Arai, The University of Tokyo

Can We Get Away from the Attrition-based Model? Opportunities to Turn around Pharma R&D Productivity

Jean-Jacques Garaud
Head of Pharma Research and Early Development, Pharmaceuticals Div.,
F. Hoffmann-La Roche Ltd.

Bringing DNA Sequences to Life: Synthetic Genes, Genomes, and Cells

Clyde A. Hutchison Ⅲ
Distinguished Professor, Synthetic Biology and Bioenergy,
J. Craig Venter Institute /
A Member of the National Academy of Sceiences

Creating Golden Opportunities for Biotechnology in the Yellow Sea Region: Importance of Regional Cross-border Alliance between Japan, China and Korea

Sunyoung Kim
Managing Director, Office of Strategic R&D Planning,
Ministry of Knowledge Economy/
Professor, Seoul National University

IPJ-K

Concurrent Conference

Keynote Session [IPJ-K]

June 29 (Wed) 10:30 - 12:30 Bilingual (English/Japanese)

How Can We Survive Turbulent Pharmaceutical Industry?

Kyowa Hakko Kirin Takes Step toward a Global Specialty Pharmaceutical Company

Yuzuru Matsuda
Executive Director of the Board,
President & Chief Executive Officer,
Kyowa Hakko Kirin Co., Ltd.

Sandoz Biosimilars: Pioneering the Future

Shreeram Aradhye
Head Global Clinical Development & Medical Affairs,
Biopharmaceuticals Development,
Sandoz International GmbH

COSME-K

[Attend sessions for free by registering "member registration"]

COSMETICS JAPAN

Keynote Session [COSME-K]

June 30 (Thur) 10:30 - 12:00Bilingual (English/Japanese)

Time for the Change!
-Keys to Open up the Future of the Japan Cosmetics Industry-

Roadmap to a Truly Prestigious Cosmetics and Beauty Solutions Provider

Shoichi Kobayashi
President and Chief Executive Officer,
Albion Co., Ltd.　

JPY 30 Billion Annual Sales in Six Years! Yuuka Reveals the Key to its Striking Growth

Keiichiro Nakayama
CEO,　
Yuuka. Co., Ltd.

BIO-10ブロック

10th Anniversary Session

Bilingual (English/Japanese)June 30 [Thur] 15:50-17:20

Who Holds the Keys to Re-energize the World?

World's First of iPS Cell Generation! Leading Candidate for the Nobel Prize

Shinya Yamanaka
Director,
Center for iPS Cell Research and Application (CiRA),
Kyoto University

Award Winner of the Nobel Prize in Chemistry 2002, Established Protein Mass Spectrometry

Koichi Tanaka
Fellow, General Manager,
Koichi Tanaka Lab. Of Advanced Science and Technology,
Shimadzu Corp.

BIO-1ブロック

Special Session 1

Bilingual (English/Japanese)June 29 [Wed] 10:30-12:00

Does Epi-Genome Research Open the World for New Therapy?

Session Chair: Tatsumi Yamazaki, Chugai Pharmaceutical Co., Ltd.

Epigenetic Regulation of Induced Pluripotent Stem Cells

Yasuhiro Yamada
Professor, Center for iPS Cell Research and Application(CiRA)
Kyoto University

Target Discovery in Cancer Epigenomics

Hiroyuki Aburatani
Professor, Genome Science Div., RCAST
The University of Tokyo

BIO-2ブロック

Special Session 2

Bilingual (English/Japanese)June 30 [Thur] 10:30-12:00

For the Recovery of Biomedical Industry of Japan and the Future of Regulatory Affairs

Session Chair: Koji　Kawakami, Kyoto University

Promotion of Medical Innovation and Regulatory Authorities’ Challenge

Yoshinobu Hirayama
Councilor for Pharmaceutical Affairs,
Minister's Secretariat
Ministry of Health,
Labour and Welfare

Challenges and Strategic Approaches of Japan

Kiyoshi Kurokawa
Professor,
National Graduate Institute for Policy Studies

Photo: Tetsuo SAKUMA

BIO-3ブロック

Special Session 3

Bilingual (English/Japanese)June 30 [Thur] 10:30-12:00

Catch-up Development of Made-in-Japan Vaccines!

Session Chair: Toichi Takenaka, Astellas Pharma Inc.

The Development of the Next Generation Vaccines for Infectious Diseases

Koichi Yamanishi
Director General
National Institute of Biomedical Innovation(NIBIO)

Development of New Recombinant Influenza Vaccines Manufactured by Insect Cell Culture

Shu-ichi Kanazashi
Chief Exective Officer
UMN Pharma Inc.

BIO-4ブロック

Special Session 4

Bilingual (English/Japanese)June 30 [Thur] 13:00-14:30

Young Star Pioneers Open Up Frontier of Tissue Engineering and Cancer Diagnosis Innovation by Nanobio Research

Session Chair: Yoshinobu Baba, Nagoya University

3D Tissue Construction with Microfluidic Technology

Shoji Takeuchi
Associate Professor,
Institute of Indusrial Science and,
Director, Collaborative Research Center for Bio Nano Hybrid Process
The University of Tokyo

In Vivo Tumor Imaging with Rationally Designed Fluorescence Probes

Yasuteru Urano
Professor,
Lab. of Chemical Biology & Molecular Imaging,Graduate School of Medicine,
The University of Tokyo

BIO-5ブロック

Special Session 5

Bilingual (English/Japanese)June 30 [Thur] 13:00-14:30

IP System for Global Business

Session Chair: Hiroshi Akimoto, Intellectual Property Strategy Network, Inc.

How IP Contributes in Pharmaceutical Industries

Kazuo Sato
General Manager　
Intellectual Property,
Daiichi Sankyo Co., Ltd.

God is in the Details

Hirohiko Nakahara
Director,
Intellectual Property Policy Office, Economic and Industrial Policy Bureau,
Ministry of Economy, Trade and Industry

Use of Intellectual Property under Open Innovation
--Focusing on Issues Related to Usage Agreements for Jointly Owned Patent Rights

Masayasu Ishida
Part-time instructor,
Dept. of Intellectual Property Strategy, Graduate School of Management of Science and Technology,
Tokyo University of Science

BIO-6ブロック

Special Session 6

Bilingual (English/Japanese)July 1 [Fri] 10:30-12:00

Global Frontier of ES/iPS Cell Application in Cell Therapy and Drug Screening

Session Chair: Norio Nakatsuji, Kyoto University

Development of Human Embryonic Stem-Cell Based Therapies for the Treatment of Human Degenerative Diseases

Katharine E. Spink
Senior Vice President,
Alliance Management And Cell Therapy Product Development,
Geron Corp.

※Please note that speaker has changed as above

Human ES/iPS Cell Lines for Drug Discovery: Creation of Model Cells with Genetic Modification and/or Chemical Biology for Disease Mechanism Study and Drug Screening

Norio Nakatsuji
Director,
Institute for Integrated Cell-Material Sciences,
Kyoto University

BIO-7ブロック

Special Session 7

Bilingual (English/Japanese)July 1 [Fri] 10:30-12:00

Drug Discovery Initiative in Academic Sector in China and Japan

Session Chair: Sumio Sugano, The University of Tokyo

Open Innovation for Drug Discovery in Japan

Tetsuo Nagano
Dean, Professor,
Graduate School of Pharmceutical Sciences
The University of Tokyo

New Effort of Drug Discovery in China

Cheng Yang
Vice President,
Tianjin International Joint Academy of Biotechnology and Medicine,

※Please note that speaker has changed as above
　due to the speakers schedule.(As of April 22nd)